Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Phytother Res ; 27(4): 564-71, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22678994

ABSTRACT

Mitochondrial membrane potential (∆Ψm ) contributes to determining a driving force for calcium to enter the mitochondria. It has been demonstrated that even a small mitochondrial depolarization is sufficient to prevent mitochondrial calcium overload and the subsequent apoptosis. Therefore, mild mitochondrial depolarization has been recently evaluated as a novel mechanism of neuroprotection via inhibiting neurotoxic mitochondrial calcium overload during neuronal insults. In the present study, using both real-time recording and flow cytometric analyses of ∆Ψm , we demonstrated that ethanolic peel extract of Citrus sunki Hort. ex Tanaka (CPE) and its active compounds are capable of inducing a mild mitochondrial depolarization. Polymethoxylated flavones such as nobiletin and tangeretin were found as the active compounds responsible for CPE effects on ∆Ψm . Neuronal viability was significantly increased in a dose-dependent manner by CPE treatment in H2 O2 -stimulated HT-22 cells as an in vitro neuronal insult model. CPE treatment significantly inhibited H2 O2 -induced apoptotic processes such as chromatin condensation, caspase 3 activation and anti-poly (ADP-ribose) polymerase (PARP) cleavage. CPE treatment significantly blocked mitochondrial calcium overload in H2 O2 -stimulated HT-22 neurons as indicated by rhod-2 acetoxymethyl ester. Taken together, our findings suggest that CPE and its active compounds may be considered as promising neuroprotective agents via inducing a mild mitochondrial depolarization.


Subject(s)
Citrus/chemistry , Membrane Potential, Mitochondrial/drug effects , Neurons/drug effects , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Apoptosis , Calcium/metabolism , Cell Line , Flavones/pharmacology , Flow Cytometry , Fruit/chemistry , Humans , Hydrogen Peroxide/pharmacology , Mitochondria/drug effects
2.
Biol Pharm Bull ; 33(11): 1814-21, 2010.
Article in English | MEDLINE | ID: mdl-21048305

ABSTRACT

A growing body of evidence suggests that nobiletin (5,6,7,8,3',4'-hexamethoxy flavone) from the peel of citrus fruits, enhances the damaged cognitive function in disease animal models. However, the neuroprotective mechanism has not been clearly elucidated. Since nobiletin has shown anti-inflammatory effects in several tissues, we investigated whether nobiletin suppresses excessive microglial activation implicated in neurotoxicity in lipopolysaccharide (LPS)-stimulated BV-2 microglia cell culture models. Release of nitric oxide (NO), the major inflammatory mediator in microglia, was markedly suppressed in a dose-dependent manner following nobiletin treatment (1-50 µM) in LPS-stimulated BV-2 microglia cells. The inhibitory effect of nobiletin was similar to that of minocycline, a well-known microglial inactivator. Nobiletin significantly inhibited the release of the pro-inflammatory cytokine tumor necrosis factor (TNF-α) and interleukin-1ß (IL-1ß). LPS-induced phosphorylations of extracellular signal-regulated kinase (ERK), c-Jun NH(2)-terminal kinase (JNK), and p38 mitogen-activated protein kinases (MAPKs) were also significantly inhibited by nobiletin treatment. In addition, nobiletin markedly inhibited the LPS-induced pro-inflammatory transcription factor nuclear factor κB (NF-κB) signaling pathway by suppressing nuclear NF-κB translocation from the cytoplasm and subsequent expression of NF-κB in the nucleus. Taken together, these results may contribute to further exploration of the therapeutic potential and molecular mechanism of nobiletin in relation to neuroinflammation and neurodegenerative diseases.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Citrus/chemistry , Inflammation/drug therapy , Microglia/drug effects , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Animals , Biological Transport/drug effects , Cell Line , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cytokines/antagonists & inhibitors , Cytoplasm/drug effects , Dose-Response Relationship, Drug , Fruit , Inflammation/metabolism , Lipopolysaccharides , Mice , Microglia/metabolism , Minocycline/pharmacology , Mitogen-Activated Protein Kinases/antagonists & inhibitors , NF-kappa B/antagonists & inhibitors , Neurodegenerative Diseases/drug therapy , Nitric Oxide/antagonists & inhibitors , Phosphorylation , Phytotherapy , Signal Transduction/drug effects
3.
Biol Pharm Bull ; 32(10): 1760-4, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19801840

ABSTRACT

The antitumor activity of fucoidan from Fucus vesiculosus was investigated in human colon carcinoma cells. The crude fucoidan, a polysaccharide composed predominantly of sulfated fucose, markedly inhibited the growth of HCT-15 cells (human colon carcinoma cells). After HCT-15 cells were treated with fucoidan, several apoptotic events such as DNA fragmentation, chromatin condensation and increase of the population of sub-G1 hypodiploid cells were observed. In the mechanism of fucoidan-induced apoptosis, we examined changes in Bcl-2 and Bax protein expression levels and activation of caspases. Fucoidan decreased Bcl-2 expression, whereas the expression of Bax was increased in a time-dependent manner compared to the control. In addition, the active forms of caspase-9 and caspase-3 were increased, and the cleavage of poly(ADP-ribose) polymerase (PARP), a vital substrate of effector caspase, was observed. Furthermore, the induction of apoptosis was also accompanied by a strong activation of extracellular signal-regulated kinase (ERK) and p38 kinase and an inactivation of phosphatidylinositol 3-kinase (PI3K)/Akt in a time-dependent manner. These findings provide evidence demonstrating that the pro-apoptotic effect of fucoidan is mediated through the activation of ERK, p38 and the blocking of the PI3K/Akt signal pathway in HCT-15 cells. These data support the hypothesis that fucoidan may have potential in colon cancer treatment.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents, Phytogenic/therapeutic use , Apoptosis/drug effects , Colonic Neoplasms/drug therapy , Fucus/chemistry , Plant Extracts/therapeutic use , Polysaccharides/therapeutic use , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Antineoplastic Agents, Phytogenic/pharmacology , Caspase 3/metabolism , Caspase 9/metabolism , Cell Line, Tumor , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Phosphatidylinositol 3-Kinases/metabolism , Phytotherapy , Plant Extracts/pharmacology , Poly(ADP-ribose) Polymerases/metabolism , Polysaccharides/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
4.
Cancer Lett ; 205(1): 31-8, 2004 Mar 08.
Article in English | MEDLINE | ID: mdl-15036658

ABSTRACT

This study examined the inhibitory effect of Eurya emarginata extracts on the growth of cancer cells. The ethylacetate (EtOAc) fraction of the E. emarginata leaves markedly inhibited the growth of leukemia cells including HL-60. When the HL-60 cells were treated with its EtOAc fraction, DNA fragmentation and sub-G1 hypodiploid cells were observed. Moreover, the EtOAc fraction of E. emarginata reduced the c-Myc and Bcl-2 protein and mRNA levels in a time-dependent manner, whereas the Bax protein and mRNA expression levels were slightly increased. The results suggest that the inhibitory effect of E. emarginata on the growth of HL-60 appears to arise from the induction of apoptosis via the down-regulation of Bcl-2 and c-Myc expression with an increase in the Bax expression level.


Subject(s)
Anticarcinogenic Agents/pharmacology , Apoptosis/drug effects , Leukemia/drug therapy , Plant Extracts/pharmacology , Blotting, Western , Cell Division/drug effects , HL-60 Cells , Humans , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/drug effects , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/drug effects , Proto-Oncogene Proteins c-myc/biosynthesis , Proto-Oncogene Proteins c-myc/drug effects , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , bcl-2-Associated X Protein
SELECTION OF CITATIONS
SEARCH DETAIL